<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title-group><journal-title>Molecular Vision</journal-title></journal-title-group><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">177</article-id><article-id pub-id-type="publisher-id">2009MOLVIS0045</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Sclera-related gene polymorphisms in high myopia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lin</surname><given-names>Hui-Ju</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wan</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tsai</surname><given-names>Yuhsin</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Su-Ching</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Wen-Chi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tsai</surname><given-names>Shih-Wei</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tsai</surname><given-names>Fuu-Jen</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><aff id="aff1"><label>1</label>Department of Ophthalmology, China Medical University Hospital, Taichung, Taiwan</aff><aff id="aff2"><label>2</label>Department of Medical Genetics, China Medical University Hospital, Taichung, Taiwan</aff><aff id="aff3"><label>3</label>School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan</aff><aff id="aff4"><label>4</label>Department of Biotechnology, Asia University, Taichung, Taiwan</aff><aff id="aff5"><label>5</label>Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan</aff><aff id="aff6"><label>6</label>Institute of Environmental Health, College of Public Health, National Taiwan University, Taipei, Taiwan</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to: Lei Wan, Ph.D., Department of Medical Genetics, China Medical University Hospital, No. 2 Yuh Der Road, Taichung 404, Taiwan; Phone: 886-4-22052121 ext. 2041; FAX: 886-4-22033295; email: <email xlink:href="d0704@mail.cmuh.org.tw">d0704@mail.cmuh.org.tw</email></corresp></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>20</day><month>8</month><year>2009</year></pub-date><volume>15</volume><fpage>1655</fpage><lpage>1663</lpage><history><date date-type="received"><day>15</day><month>2</month><year>2009</year></date><date date-type="accepted"><day>16</day><month>8</month><year>2009</year></date></history><permissions><copyright-year>2009</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>Transforming growth factor-&#x003b2;2 (TGF-&#x003b2;2), basic fibroblast growth factor (bFGF), and fibromodulin (FMOD) are important extracellular matrix components of the sclera and have been shown to be associated with the development of high myopia. Our aim was to examine the association between myopia and the polymorphisms within <italic>TGF-&#x003b2;2</italic>, <italic>bFGF</italic>, and <italic>FMOD</italic>.</p></sec><sec><title>Methods</title><p>The study group comprised of patients (n=195; age range: 17&#x02212;24 years) with a spherical equivalent of &#x02212;6.5 diopters (D) or a more negative refractive error. The control group comprised of individuals (n=94; age range: 17&#x02212;25 years) with a spherical equivalent ranging from &#x02212;0.5 D to +1.0 D. The subjects with astigmatism over &#x02013;0.75 D were excluded from the study. High resolution melting (HRM) genotyping and restriction fragment length polymorphism (RFLP) genotyping were used to detect single nucleotide polymorphisms (SNPs). The polymorphisms detected were <italic>TGF-&#x003b2;2</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=991967">rs991967</ext-link>), <italic>bFGF</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=308395">rs308395</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=41348645">rs41348645</ext-link>), and <italic>FMOD</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7543418">rs7543418</ext-link>). Moreover, a stepwise logistic regression procedure was used to detect which of the significant SNPs contributed to the main effects of myopia development.</p></sec><sec><title>Results</title><p>There were significant differences in the frequency of the A allele and A/A genotype in <italic>TGF-&#x003b2;2 </italic>(<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>; p=0.0178 and 0.03, respectively). Moreover, the haplotype distribution of haplotype 2 (Ht2; A/A) of <italic>TGF-&#x003b2;2</italic> differed significantly between the two groups (p=0.014). The results of the stepwise logistic regression procedure revealed that <italic>TGF-&#x003b2;2</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>) contributed significantly to the development of high myopia.</p></sec><sec><title>Conclusions</title><p>TGF-&#x003b2;2 is an important structure of sclera and might contribute to the formation of myopia. <italic>TGF-&#x003b2;2 </italic>(<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>) polymorphisms, A allele and A/A genotype, had a protective role against the development of high myopia.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta><custom-meta><meta-name>corr-author</meta-name><meta-value>Wan</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>The prevalence of myopia ranges from 20% to 30% in North American, European, and Australian populations [<xref ref-type="bibr" rid="r1">1</xref>] and is as high as 90% in Asian populations [<xref ref-type="bibr" rid="r2">2</xref>,<xref ref-type="bibr" rid="r3">3</xref>]. Low to moderate degrees of myopia present a relatively minor inconvenience as the symptoms are easily corrected using spectacles or contact lenses. High degrees of myopia, while also correctable using these optical approaches, are of major concern because of the increased risk of myopia-related pathology such as chorioretinal degeneration and retinal detachment [<xref ref-type="bibr" rid="r4">4</xref>]. The ocular pathology associated with high myopia is among the leading causes of registered blindness in the developed world [<xref ref-type="bibr" rid="r5">5</xref>].</p><p>Many studies have suggested that myopia is a complex disease with multiple causes, including the interaction of multiple genes with environmental stimuli [<xref ref-type="bibr" rid="r6">6</xref>]. Therefore, it is necessary to take both genes and environment into account to understand myopia [<xref ref-type="bibr" rid="r6">6</xref>]. As for pathogenesis of high myopia, studies of high myopia in animal models have demonstrated that increasing eye size facilitated by remodeling of the sclera was one of the most important etiologies in the progression of myopia [<xref ref-type="bibr" rid="r7">7</xref>]. The sclera consists of fibrous connective tissue comprised largely of heterologous collagen fibrils, which are in turn composed mainly of type I collagen with small amounts of other fibrillar and fibril-associated collagens [<xref ref-type="bibr" rid="r8">8</xref>]. An important candidate in the search for factors involved in scleral remodeling in myopia is transforming growth factor-&#x003b2; (TGF-&#x003b2;). Transforming growth factor-&#x003b2; is known to initiate myofibroblast formation and fibrosis [<xref ref-type="bibr" rid="r9">9</xref>]. Although five members of the TGF-&#x003b2; family have currently been identified, only TGF-&#x003b2; isoforms 1, 2, and 3 have been detected in eyes and TGF-&#x003b2;2 is the predominant form [<xref ref-type="bibr" rid="r9">9</xref>,<xref ref-type="bibr" rid="r10">10</xref>].</p><p>In addition to TGF-&#x003b2;, basic fibroblast growth factors (bFGFs) are also involved in the remodeling of sclera. bFGFs with their receptors (FGFRs) and signaling cascades are involved in a diverse range of cellular processes including proliferation, apoptosis, cell survival, chemotaxis, cell adhesion, motility, and differentiation. bFGF-2 is a potent mitogen for fibroblasts and myofibroblasts [<xref ref-type="bibr" rid="r11">11</xref>]. Moreover, the major extracellular matrix components of the fibrous mammalian sclera are collagen types I and III and the small leucine rich proteoglycans (SLRPs), which include decorin, biglycan, lumican, and fibromodulin (FMOD) [<xref ref-type="bibr" rid="r12">12</xref>]. There is considerable evidence that FMOD is involved in regulating the formation of the network of collagen fibrils that makes up the extracellular matrix [<xref ref-type="bibr" rid="r13">13</xref>]. Among the polymorphisms, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link> (<italic>TGF-&#x003b2;2</italic>) and&#x000a0;<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=308395">rs308395</ext-link> (<italic>bFGF</italic>)&#x000a0;are found in the promoter region and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=991967">rs991967</ext-link> (<italic>TGF-&#x003b2;2</italic>) and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=41348645">rs41348645</ext-link><italic/>(<italic>bFGF</italic>)&#x000a0;are found in the 3&#x02032;-UTR region. Polymorphisms in 5&#x02032;-UTR and 3&#x02032;-UTR might have effects on the translation and stability of the genes. We selected these polymorphisms as candidates in this study.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Patients</title><p>From February to November 2004, we measured the refractive error in 3,000 volunteers. All of the participants were medical students, unrelated and Taiwan-born Han Chinese (<xref ref-type="table" rid="t1">Table 1</xref>). The included subjects had a visual acuity with distance correction of 0.2 logMAR (logarithm of the minimal angle of resolution; 20/32) or better. The included subjects did not have any systemic diseases. They also did not receive ocular surgery before. Refractive error was measured in diopters (D) and determined by the mean spherical equivalent (SE) of the two eyes of each individual after administering one drop of cycloplegic drug (1% mydricyl; Alcon, Berlin, Germany). Individuals with &#x02212;6.5 D or a more negative refractive error (both eyes) were included in the study group, and those with myopia between &#x02212;0.5 D and +1.0 D (both eyes) were included in the control group. Patients with astigmatism with a refractive error more negative than -0.75 D were excluded from the study. Other volunteers did not meet the criteria to be included in either the study or control groups, and they were excluded from our study. Our study was reviewed by the ethics committee, and informed consent was obtained from all patients and control subjects. The study was performed according to the tenets of the Declaration of Helsinki for research involving human subjects. Comprehensive ophthalmic examinations and blood collection were performed. As with all data collection procedures, auto-refraction (Auto-refractor/auto-keratometer; ARK 700A; Nikon, Tokyo, Japan) was taken on both eyes by experienced optometrists who were trained and certified on study protocols. Refractive data, sphere(s), negative cylinder&#x000a9;, and axis measurements were analyzed by calculating refractive error with SE.</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Characteristics of the study subjects.</title></caption><table frame="hsides" rules="groups"><col width="140" span="1"/><col width="105" span="1"/><col width="122" span="1"/><col width="122" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Characteristics</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Control (n=94)</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Cases (n=195)</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>All subjects (n=289)</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age, mean (SD), yr<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">18 (2.9)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">18 (3.4)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">18 (3.2)<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Female, Number (%)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">33 (35.1%)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">70 (35.9%)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">103 (35.6%)<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">SE, mean (SD), D<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.02 (0.32)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;8.83 (2.5)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;4.5 (4.8)<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">AXL, mean (SD), mm<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">23.56 (0.78)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">26.8 (1.8)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">24.8 (2.5)<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">CD, mean (SD), D<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">43.5 (0.9)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">44.2 (1.9)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">43.8 (1.5)<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">ACD, mean (SD), mm<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">3.56 (0.25)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">3.88 (0.33)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">3.62 (0.3)<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">LT, mean (SD), mm</td><td valign="top" align="left" rowspan="1" colspan="1">3.8 (0.65)</td><td valign="top" align="left" rowspan="1" colspan="1">4.0 (0.58)</td><td valign="top" align="left" rowspan="1" colspan="1">3.9 (0.6)</td></tr></tbody></table><table-wrap-foot><p>SE: spherical equivalent, AXL: axial length, CD: cornea diopter, ACD: anterior chamber depth, LT: lens thickness.</p></table-wrap-foot></table-wrap></sec><sec><title>Genotype determinations</title><p>The single nucleotide polymorphisms (SNPs) were selected based on three criteria. (1) The selected SNP had a frequency in the CHB (Han Chinese in Beijing, China) or JPN<ext-link ext-link-type="uri" xlink:href="http://(">(</ext-link>Japanese) population as documented in the <ext-link ext-link-type="uri" xlink:href="http://www.hapmap.org/">HapMap</ext-link> project, and the heterozygosity should be more than 10%. (2) The selected SNP should be in the region of the promoter, 5&#x02032;-UTR, exons, and 3&#x02032;-UTR of the gene. We excluded any intron SNP because it is hard to predict the outcome of the polymorphism. (3) In exons, only non-synonymous SNPs were selected. Based on these criteria, only a few SNPs could be selected. For <italic>FMOD</italic>, the selected SNP was based on sequencing experiments. The exons of <italic>FMOD</italic> were sequenced among 50 randomly selected individuals to reveal the SNPs in <italic>FMOD</italic>. Only one SNP was detected. As for selecting haplotype, <ext-link ext-link-type="uri" xlink:href="http://www.hapmap.org/">HapMap</ext-link> genotypes were analysed within <ext-link ext-link-type="uri" xlink:href="http://www.broadinstitute.org/haploview">Haploview</ext-link> and tag SNPs were selected using <ext-link ext-link-type="uri" xlink:href="http://www.broadinstitute.org/mpg/tagger">tagger</ext-link>. Four tag SNPs were selected for each gene with r<sup>2</sup>&#x02265;0.80 to capture 80% of genotype information in the region. The average tag SNP was with r<sup>2</sup>=0.901.</p><p>In this study, we used high resolution melting (HRM) genotyping and restriction fragment length polymorphism (RFLP) genotyping to detect the SNPs. Genomic DNA was extracted from whole blood samples after a standard protocol of digestion by proteinase K and purification with phenol-chloroform. RFLP was used to detect genotypes of <italic>TGF-b2 </italic>(<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=991967">rs991967</ext-link>), <italic>bFGF</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=308395">rs308395</ext-link>), and <italic>FMOD</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7543148">rs7543148</ext-link>). The amplification protocol and restriction enzymes used to determine the genotype are listed in <xref ref-type="table" rid="t2">Table 2</xref>. Preventive contamination measures were taken by including a polymerase chain reaction (PCR) reaction mixture without DNA (negative control) in each run of amplification. The DNA fragments were separated by horizontal electrophoresis on 3% agarose gels, stained with ethidium bromide, and photographed under ultraviolet lights. Data were analyzed by ABI prism GeneMapper Version 3.0 software (Applied Biosystems Co, Foster City, CA). The PCR product of <italic>TGF-&#x003b2;2</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=991967">rs991967</ext-link>) was digested with HpyCH4III (New England Biolabs, Mississauga, Ontario, Canada). The A allele size was 239 bp, and the C allele size was 100 bp+139 bp as shown in <xref ref-type="fig" rid="f1">Figure 1</xref>. The PCR product of <italic>bFGF</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=308395">rs308395</ext-link>) polymorphism was digested with BsrI (New England Biolabs). The C allele size was 241 bp, and the G allele size was 163 bp+78 bp as shown in <xref ref-type="fig" rid="f2">Figure 2</xref>. The PCR product of the <italic>FMOD</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7543148">rs7543148</ext-link>) genetic polymorphism was digested with BsmI (New England Biolabs). The G allele size was 1,033 bp, and the A allele size was 751 bp+282 bp as shown in <xref ref-type="fig" rid="f3">Figure 3</xref>.</p><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>Conditions of PCR and HRM. The primer pairs, condition, product size, and restriction enzyme of <italic>TGF-&#x003b2;2</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=991967">rs991967</ext-link>), <italic>bFGF</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3083959">rs308395</ext-link>) in the PCR-RFLP and <italic>TGF-&#x003b2;2 </italic>(<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>) and <italic>bFGF </italic>(<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=41348645">rs41348645</ext-link>) in the reaction of HRM reaction.</title></caption><table frame="hsides" rules="groups"><col width="86" span="1"/><col width="249" span="1"/><col width="81" span="1"/><col width="81" span="1"/><col width="67" span="1"/><col width="44" span="1"/><col width="61" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Sequence Polymorphism (rs number)</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Primer</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>PCR Product size (bp)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>PCR conditions (annealing temperature)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Restriction enzyme site</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Alleles</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>DNA Fragment size (bp)</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>TGF-&#x003b2;2</italic><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=991967">rs991967</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F: 5&#x02032;-TGACCGAGAAAGTCTGCATT-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">239<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55&#x000a0;&#x000b0;C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">HpyCH4III<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">239<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R: 5&#x02032;-AAGGTCTGAAGTTTGACCAGTACA-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">100+139<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>bFGF</italic><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3083959">rs308395</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F: 5&#x02032;-GCATGGCCTTTTGAAACCTA-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">241<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55&#x000a0;&#x000b0;C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">BsrI<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">241<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R: 5&#x02032;-CAGCGTCTCACACACTGAGG-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">163+78<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>FMOD</italic><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7543148">rs7543148</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F: 5&#x02032;-GCTGG CTTGC TCTGT TCTCT-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1033<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55&#x000a0;&#x000b0;C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">BsmI<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1033<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R: 5&#x02032;-GCCAA GGTCT CACCA TTGAT-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">751+282<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Sequence Polymorphism (rs number)</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>Primer</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>DNA concentration</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Mg concentration</bold><hr/></td><td colspan="2" valign="top" align="center" rowspan="1"><bold>PCR conditions (annealing temperature)</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Alleles</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>TGF-&#x003b2;2</italic><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F: 5&#x02032;-AACGGGAGACTTGATTGTCCT-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.8 ng<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2 mM<hr/></td><td colspan="2" valign="top" align="center" rowspan="1">touchdown 60/53&#x000a0;&#x000b0;C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R: 5&#x02032;-CGAACCGTTGAGGGAGTGT-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td colspan="2" valign="top" align="center" rowspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>bFGF</italic><ext-link ext-link-type="uri" xlink:href="rs41348645">rs41348645</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F: 5&#x02032;-ACCATAGACTGTCTTACCCA-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.8 ng<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2 mM<hr/></td><td colspan="2" valign="top" align="center" rowspan="1">touchdown 60/53&#x000a0;&#x000b0;C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="left" rowspan="1" colspan="1">R: 5&#x02032;-CAATTGTAAGGGAAGTCAGC-3</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;</td><td colspan="2" valign="top" align="center" rowspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">G</td></tr></tbody></table></table-wrap><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>The PCR product of <italic>TGF-&#x003b2;2</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=991967">rs991967</ext-link>) genetic polymorphism The PCR product of <italic>TGF&#x003b2;2</italic>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=991967">rs991967</ext-link> was digested with HpyCH4III. The &#x0201c;<italic>A</italic>&#x0201d; allele was 239 bp and the &#x0201c;<italic>C</italic>&#x0201d; allele was 100 bp + 139 bp.</p></caption><graphic xlink:href="mv-v15-1655-f1"/></fig><fig id="f2" fig-type="figure" position="float"><label>Figure 2</label><caption><p>The PCR product of <italic>bFGF </italic>(<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3083959">rs308395</ext-link>) polymorphism. The PCR product of<italic> &#x003b2;FGF2</italic>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3083959">rs308395</ext-link> polymorphism was digested with BsrI. The &#x0201c;<italic>C</italic>&#x0201d; allele was 241 bp and the &#x0201c;<italic>G</italic>&#x0201d; allele was 163 bp + 78 bp.</p></caption><graphic xlink:href="mv-v15-1655-f2"/></fig><fig id="f3" fig-type="figure" position="float"><label>Figure 3</label><caption><p>The PCR product of<italic> FMOD</italic> exon 2 codon 79 genetic polymorphism. The PCR product of<italic> FMOD</italic> exon 2 codon 79 genetic polymorphism was digested with BsmI. The &#x0201c;<italic>G</italic>&#x0201d; allele was 1,033 bp and the &#x0201c;<italic>A</italic>&#x0201d; allele was 751 bp + 282 bp.</p></caption><graphic xlink:href="mv-v15-1655-f3"/></fig><p>In this study, HRM genotyping was used to detect the SNPs of <italic>TGF-&#x003b2;2 </italic>(<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>) and <italic>bFGF </italic>(<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=41348645">rs41348645</ext-link>). Real-time PCR amplification of the <italic>16S rRNA</italic> gene was performed in a LightCycler&#x000ae; 480 High Resolution Melting Master (Roche Diagnostics Co, Mannheim, Germany) with the primer pairs listed in <xref ref-type="table" rid="t2">Table 2</xref>. Briefly, genomic DNA (50 ng) was added to a 10 &#x000b5;l reaction mixture containing 0.5&#x000a0;&#x000b5;mol/l and 2 mmol/l MgCl<sub>2</sub> of each primer. Cycling conditions are listed in <xref ref-type="table" rid="t2">Table 2</xref>. We also compared the haplotypes of these polymorphisms in their susceptibility to high myopia. Haplotypes were inferred from unphased genotype data using the Bayesian statistical method available in the software program, <ext-link ext-link-type="uri" xlink:href="http://www.stat.washington.edu/stephens/phase">Phase 2.1</ext-link>. All five SNPs were analyzed with the <ext-link ext-link-type="uri" xlink:href="http://www.stat.washington.edu/stephens/phase">Phase 2.1</ext-link> software [<xref ref-type="bibr" rid="r14">14</xref>]. We defined haplotype 1 (Ht 1) to haplotype 4 (Ht 4) as the alternative allelic composition of the <italic>TGF-&#x003b2;2</italic> and <italic>bFGF</italic> polymorphisms. They are defined in <xref ref-type="table" rid="t3">Table 3</xref>.</p><table-wrap id="t3" position="float"><label>Table 3</label><caption><title>Gene haplotypes of <italic>TGF-&#x003b2;2</italic><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>/<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=991967">rs991967</ext-link>and <italic>&#x003b2;FGF</italic><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3083959">rs308395</ext-link>/<ext-link ext-link-type="uri" xlink:href="rs41348645">rs41348645</ext-link>.</title></caption><table frame="hsides" rules="groups"><col width="118" span="1"/><col width="59" span="1"/><col width="58" span="1"/><col width="74" span="1"/><col width="72" span="1"/><col width="96" span="1"/><col width="61" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">SNPs</th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><bold>Haplotype</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Controls (%)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Cases (%)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>OR (95% CI)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>p value</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>TGF-&#x003b2;2</italic><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>/<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=991967">rs991967</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Ht1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">126 (67.0%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">258 (66.1%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.94 (0.65&#x02013;1.35)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.736<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Ht2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A/A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">30 (16.0%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">96 (24.60%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.75 (1.12&#x02013;2.75)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.014<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Ht3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">26 (13.8%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">36 (9.20%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.64 (0.37&#x02013;1.09)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.101<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Ht4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C/A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6 (3.1 %)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0 (0.00%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">-<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N#<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>bFGF</italic><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3083959">rs308395</ext-link>/<ext-link ext-link-type="uri" xlink:href="rs41348645">rs41348645</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Ht1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C/A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">116 (61.7%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">226 (57.9%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.88 (0.62&#x02013;1.24)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.458<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Ht2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C/G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">48 (25.5%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">114 (29.2%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.2 (0.81&#x02013;1.77)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.360<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Ht3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G/A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">24 (12.8%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">32 (8.2%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.59 (0.34&#x02013;1.02)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.058<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">Ht4</td><td valign="top" align="center" rowspan="1" colspan="1">G/G</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0%)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (4.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">N#</td></tr></tbody></table><table-wrap-foot><p>#; The case number was too small and under power for analyzing.</p></table-wrap-foot></table-wrap></sec><sec><title>Statistical analysis</title><p>Genotypes were obtained by direct counting with subsequent calculation of allele frequencies. Data were analyzed using the &#x003c7;<sup>2</sup> test, and p values were calculated using the Minitab program (Minitab Inc., San Jose, CA). A p value less than 0.05 was considered significant. Adherence to the Hardy&#x02013;Weinberg equilibrium (HWE) constant was tested using a &#x003c7;<sup>2</sup> test with one degree of freedom. The odds ratios (OR) and the corresponding 95% confidence intervals (CI) were calculated with reference to the allele and genotype. Correction for multiple comparisons was performed by Bonferroni correction. For the&#x000a0;SNPs that were found to be significant after multiple&#x000a0;testing corrections, stepwise logistic regression was used to determine if any of these&#x000a0;SNPs could account for the effects of the other positive SNPs. STATA package (version 8.2; Stata Corp., College Station, TX) was used to perform the stepwise logistic regression.</p></sec></sec><sec sec-type="results"><title>Results</title><p>The volunteers who enrolled in this study all met specific criteria: age ranging from 16 to 25 years (mean age, 18&#x000b1;3.2 years), male-to-female ratio of 1.8&#x02013;1.0, mean axial length (AXL) of 24.8&#x000a0;mm, and mean spherical equivalent (SE) of 4.5 D. There were no significant differences between the control and cases groups in age, gender, cornea diopter (CD), anterior chamber depth (ACD), and LT (lens thickness; by Zeiss IOL master [Zeiss Inc, Boston, MA]; <xref ref-type="table" rid="t1">Table 1</xref>). The study group comprised of 195 patients with high myopia, and the control group consisted of 94 control subjects. The <italic>TGF-&#x003b2;2</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=991967">rs991967</ext-link>) genotypes were A/A, A/C, and C/C (<xref ref-type="fig" rid="f1">Figure 1</xref>). The genotype and allele distribution of the <italic>TGF-&#x003b2;2</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=991967">rs991967</ext-link>) polymorphism did not differ significantly between high myopia patients and normal controls (p=0.437 and p=0.169, , respectively; <xref ref-type="table" rid="t4">Table 4</xref>). The <italic>bFGF</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=308395">rs308395</ext-link>) genotypes were G/G, C/G, and C/C (<xref ref-type="fig" rid="f2">Figure 2</xref>). The genotype and allele distributions of the <italic>bFGF</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=308395">rs308395</ext-link>) polymorphism did not differ significantly between high myopia patients and normal controls (p=0.215 and p=1.0, respectively; <xref ref-type="table" rid="t4">Table 4</xref>). In the <italic>FMOD</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7543418">rs7543418</ext-link>) genetic polymorphism, the genotype and allele distributions of the <italic>FMOD</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7543418">rs7543148</ext-link>) polymorphism also did not differ significantly between high myopia patients and normal controls (p=0.362 and p=0.129, respectively; <xref ref-type="table" rid="t4">Table 4</xref>).</p><table-wrap id="t4" position="float"><label>Table 4</label><caption><title>The genotype distribution of polymorphisms between the high myopia group and control subjects.</title></caption><table frame="hsides" rules="groups"><col width="114" span="1"/><col width="60" span="1"/><col width="73" span="1"/><col width="72" span="1"/><col width="100" span="1"/><col width="84" span="1"/><col width="39" span="1"/><col width="65" span="1"/><col width="70" span="1"/><col width="92" span="1"/><col width="84" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>SNP</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Genotype</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Controls</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Cases</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>OR (95% CI)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>p-value/ Cp-value#</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Allele</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Controls</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Cases</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>OR (95% CI)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>p-value/ Cp-value#</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>TGF-&#x003b2;2</italic><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">94<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">195<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">188<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">390<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">(S1)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A/A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">63 (67%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">160 (82%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.015/0.03<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">156 (83%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">353 (91%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0089/0.0178<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1 (1%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2 (1%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.79 (0.07&#x02013;8.84)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">32 (17%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">37 (9%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.51(0.31&#x02013;0.85)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">30 (32%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">33 (17%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.43 (0.24&#x02013;0.77)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">HWEc2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.583<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.042<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>TGF-&#x003b2;2</italic><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=991967">rs991967</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">94<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">195<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.2189/0.4378<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">188<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">390<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">(S2)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">61 (65%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">109 (56%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">152 (81%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">290 (74%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0847/0.1694<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A/A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3 (3%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">14 (7%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.48 (0.68&#x02013;9.04)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">36 (19%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">100 (26%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.41(0.91&#x02013;2.17)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">30 (32%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">72 (37%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.30 (0.76&#x02013;2.21)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">HWEc2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.089<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.19<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>bFGF</italic><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3083959">rs308395</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">94<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">195<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.1078/0.2156<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">188<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">390<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">(S3)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">70 (74%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">152 (78%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">164 (87%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">341 (87%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.0/1.0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G/G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6 (3%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">-<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">24 (13%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">49 (13%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.97 (0.58&#x02013;1.62)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C/G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">24 (26%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">37 (19%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.69 (0.38&#x02013;1.24)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">HWEc2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.63<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>bFGF</italic><ext-link ext-link-type="uri" xlink:href="rs41348645">rs41348645</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">94<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">195<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0647/0.1294<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">188<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">390<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">(S4)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G/G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2 (2%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8 (4%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">48 (26%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">131 (34%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0479/0.0958<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A/A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">48 (51%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">72 (37%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.91 (0.59&#x02013;14.32)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">140 (74%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">259 (66%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.52 (1.03&#x02013;2.25)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A/G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">44 (47%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">115 (59%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.71 (1.03&#x02013;2.85)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">HWEc2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.01*<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20.2*<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>FMOD</italic><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7543148">rs7543148</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">94<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">195<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">188<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">390<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">(S5)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G/G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11 (11.7%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">12 (6.1%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.181/0.362<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">63 (34%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">106 (27.2%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.129<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A/A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">42 (44.6%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">101 (51.8%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.44 (0.19&#x02013;1.08)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">125 (66%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">284 (72.8%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.72(0.45&#x02013;1.05)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A/G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">41 (43.6%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">82(42.1%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.58 (0.22&#x02013;1.37)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">HWEc2</td><td valign="top" align="center" rowspan="1" colspan="1">0.042</td><td valign="top" align="center" rowspan="1" colspan="1">0.76</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p>#; Cp-value, p value corrected by Bonferroni correction; HWE &#x003c7;<sup>2</sup>, Hardy-Weinburg equilibrium &#x003c7;<sup>2</sup>; SNP, single nucleotide polymorphism; OR, Odds ratio; CI, confidence intervals. The asterisk indicates that the data did not obey Hardy&#x02013;Weinberg equilibrium</p></table-wrap-foot></table-wrap><p>HRM was used to detect SNPs of <italic>TGF-&#x003b2;2 </italic>(<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>) and <italic>bFGF </italic>(<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=41348645">rs41348645</ext-link>)<italic>.</italic> The <italic>TGF-&#x003b2;2</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>) genetic polymorphism was studied by HRM on a LightCycler 480. The results are shown in <xref ref-type="fig" rid="f4">Figure 4</xref>. The genotype distribution of the <italic>TGF-&#x003b2;2</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>) polymorphism differed significantly between high myopia patients and normal controls (p=0.03; <xref ref-type="table" rid="t4">Table 4</xref>). The allelic frequency also differed significantly between the two groups (p=0.0178; <xref ref-type="table" rid="t4">Table 4</xref>). The genetic polymorphism, <italic>bFGF</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=41348645">rs41348645</ext-link>), was also studied by HRM. The results are shown in <xref ref-type="fig" rid="f5">Figure 5</xref>. There was no significant difference in genotype and allele distributions of the <italic>bFGF</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=41348645">rs41348645</ext-link>) polymorphism between high myopia patients and normal controls (p=0.1294 and p=0.0958, respectively; <xref ref-type="table" rid="t4">Table 4</xref>).</p><fig id="f4" fig-type="figure" position="float"><label>Figure 4</label><caption><p>The <italic>TGF-&#x003b2;2</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>) genetic polymorphism. The <italic>TGF&#x003b2;2</italic>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link> genetic polymorphism was studied by HRM and analyzed by LightCycler 480. The <italic>TGF&#x003b2;2</italic>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link> genetic polymorphism had three genotypes and they were &#x0201c;CC&#x0201d;, &#x0201c;AC&#x0201d; and &#x0201c;AA&#x0201d;.</p></caption><graphic xlink:href="mv-v15-1655-f4"/></fig><fig id="f5" fig-type="figure" position="float"><label>Figure 5</label><caption><p>The <italic>bFGF </italic>(<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=41348645">rs41348645</ext-link>) genetic polymorphism. The <italic>&#x003b2;FGF2</italic>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=41348645">rs41348645</ext-link> genetic polymorphism was studied by HRM and analyzed by LightCycler<sup>&#x000ae;</sup> 480. The <italic>&#x003b2;FGF2</italic>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=41348645">rs41348645</ext-link> genetic polymorphism had three genotypes and they were &#x0201c;GG&#x0201d;, &#x0201c;AG&#x0201d; and &#x0201c;AA&#x0201d;.</p></caption><graphic xlink:href="mv-v15-1655-f5"/></fig><p>The haplotypes&#x02019; distribution of the <italic>TGF-&#x003b2;2</italic> polymorphisms (Ht 1 [A/C], Ht 2 [A/A], and Ht 3 [C/C]) and <italic>bFGF</italic> polymorphisms (Ht1 [C/A], Ht2 [C/G], and Ht3 [G/A]) were compared between the high myopia group and the control group (<xref ref-type="table" rid="t3">Table 3</xref>). The cases&#x02019; numbers of Ht4 in <italic>TGF-&#x003b2;2</italic> polymorphisms and Ht4 of <italic>bFGF</italic> polymorphisms were too small and under powered to analyze (<xref ref-type="table" rid="t3">Table 3</xref>). Therefore, they were excluded in this analysis. In the analysis of haplotypes, we found that the distribution of Ht 2 (A/A) in <italic>TGF-&#x003b2;2</italic> polymorphisms differed significantly between the two groups (p=0.014; <xref ref-type="table" rid="t3">Table 3</xref>). However, there was no significant difference in the distribution of Ht 1 and Ht 3 of <italic>TGF-&#x003b2;2</italic> between the two groups (p=0.736 and p=0.101; <xref ref-type="table" rid="t3">Table 3</xref>). As for the haplotypes&#x02019; distribution in <italic>FGF-2</italic>, there was no significant difference in the distribution of all haplotypes of <italic>FGF2</italic> Ht 1 (C/A), Ht 2 (C/G), and Ht 3 (G/A) between the high myopia group and the control group (p=0.458, p=0.360, and p=0.058, respectively; <xref ref-type="table" rid="t3">Table 3</xref>).</p><p>A stepwise logistic regression procedure was used to detect which of the significant SNPs contributed to the development of high myopia (<xref ref-type="table" rid="t5">Table 5</xref>). By the backward procedure, eliminated S5 (<italic>FMOD</italic> [AGT&#x02192;AAT]), S4 (<italic>bFGF</italic> [<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=41348645">rs41348645</ext-link>], S3 (<italic>bFGF</italic> [<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3083959">rs3083959</ext-link>]), and S2 (<italic>TGF-&#x003b2;2</italic> [<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=991967">rs991967</ext-link>]) from the model did not have any significant effect (p=0.3819, 0.2014, 0.128, and 0.158, respectively; <xref ref-type="table" rid="t5">Table 5</xref>). In conclusion, the stepwise regression procedure&#x000a0;demonstrated that S1 (<italic>TGF-&#x003b2;2</italic> [<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>]) significantly contributed the development of high myopia (p=0.004) (<xref ref-type="table" rid="t5">Table 5</xref>).</p><table-wrap id="t5" position="float"><label>Table 5</label><caption><title>SNPs analyzed by stepwise logistic regression procedure</title></caption><table frame="hsides" rules="groups"><col width="163" span="1"/><col width="163" span="1"/><col width="163" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Null model</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Alternative model</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>p value</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">S1+S2+S3+S4+S5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">S1+S2+S3+S4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.3819<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">S1+S2+S3+S4+S5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">S1+ S2+S3+S5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.2014<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">S1+S2+S3+S4+S5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">S1+S2+S4+S5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.128<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">S1+S2+S3+S4+S5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">S1+S3+S4+S5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.158<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">S1+S2+S3+S4+S5</td><td valign="top" align="left" rowspan="1" colspan="1">S2+S3+S4+S5</td><td valign="top" align="left" rowspan="1" colspan="1">0.004</td></tr></tbody></table><table-wrap-foot><p>S1: <italic>TGF-&#x003b2;2</italic>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>, S2: <italic>TGF-&#x003b2;2</italic>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=991967">rs991967</ext-link>, S3: <italic>&#x003b2;FGF</italic>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3083959">rs308395</ext-link>, S4: <italic>&#x003b2;FGF</italic>-<ext-link ext-link-type="uri" xlink:href="rs41348645">rs41348645</ext-link>, S5: <italic>FMOD</italic>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7543148">rs7543148</ext-link>.</p></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>Some genes have been found to be closely related to high myopia such as matrix metalloproteinases [<xref ref-type="bibr" rid="r15">15</xref>], paired box 6 [<xref ref-type="bibr" rid="r16">16</xref>], myocilin [<xref ref-type="bibr" rid="r17">17</xref>], <italic>TGF-&#x003b2;1</italic> [<xref ref-type="bibr" rid="r18">18</xref>], Paired box gene 6 (<italic>PAX-6</italic>) [<xref ref-type="bibr" rid="r19">19</xref>], and Collagen, type I, alpha 1 (<italic>COL1A1</italic>) [<xref ref-type="bibr" rid="r20">20</xref>]. These genes all indicate an evident predisposition for the development of high myopia. However, none of these genes have been found to be solely responsible for the development of myopia in different ethnic groups or to cover all myopia patients [<xref ref-type="bibr" rid="r15">15</xref>-<xref ref-type="bibr" rid="r21">21</xref>]. The other difficulty in myopic study is the uncertainty of what are the surrounding environmental influences that promote the progression of myopia. Individuals with a higher education have a higher prevalence of myopia than people in the general population, which is why students in a medical school were chosen as candidates in this study. The medical school&#x02019;s students in this study decreased the bias of environmental influence.</p><p>In this study, we found that the distribution of the <italic>TGF-&#x003b2;2</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>) A/A genotype and A allele differed significantly between the myopia and control groups. The A/A genotype and A allele of <italic>TGF-&#x003b2;2</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>) had a protective effect against myopia (<xref ref-type="table" rid="t4">Table 4</xref>). In the analysis of haplotypes, we found that Ht 2 (A/A) of <italic>TGF-&#x003b2;2</italic> was significantly different in the incidence of high myopia. The frequency of the Ht 2 (A/A) of <italic>TGF-&#x003b2;2</italic> was higher in the control group then in the myopia group (p=0.014), indicating that Ht 2 of <italic>TGF-&#x003b2;2</italic> polymorphisms had a protective effect against myopia. In <italic>TGF-&#x003b2;2</italic>, combining the analyses of allelic and haplotype study, we could indicate that the A allele of <italic>TGF-&#x003b2;2</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>) had a protective effect against high myopia, and its effect would increase when the subjects had the A allele in <italic>TGF-&#x003b2;2</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=991967">rs991967</ext-link>; Ht2 [A/A] of <italic>TGF-&#x003b2;2</italic>; <xref ref-type="table" rid="t3">Table 3</xref>). As for <italic>bFGF,</italic> the frequencies of the haplotypes were all without significant differences between the two groups (<xref ref-type="table" rid="t3">Table 3</xref>). According to our study, the genetic polymorphisms in <italic>bFGF</italic> did not play any important role in the suffering of high myopia. Besides, the results of stepwise regression procedure&#x000a0;demonstrated that S1 (<italic>TGF-&#x003b2;2</italic> [<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>]) contributed significantly to the development of myopia (p=0.04) (<xref ref-type="table" rid="t5">Table 5</xref>). There were no significant effects when S5 (<italic>FMOD</italic> [<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7543148">rs7543148</ext-link>]), S4 (<italic>bFGF</italic> [<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=41348645">rs41348645</ext-link>]), S3 (<italic>bFGF</italic> [<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3083959">rs3083959</ext-link>]), and S2 (<italic>TGF-&#x003b2;2</italic> [<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=991967">rs991967</ext-link>]) were eliminated from the model (<xref ref-type="table" rid="t5">Table 5</xref>). This also reinforced the importance of <italic>TGF-&#x003b2;2</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link>) in the development of high myopia. In the check of the Hardy&#x02013;Weinberg equilibrium (HWE), all SNPs in this study obeyed HWE except <italic>bFGF </italic>(<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=41348645">rs41348645</ext-link>; <xref ref-type="table" rid="t4">Table 4</xref>). To validate our findings, we repeated the genotyping analysis several times and consistent results were obtained. The errors in genotyping were kept to a minimum. We tried to trace the ancestry background of the controls and patients to check the probability of population stratification. According to the paper published by Pan et al. [<xref ref-type="bibr" rid="r22">22</xref>], they mentioned that on the SNP profiles in the major histocompatibility complex (MHC) region (6p21.3), the composition of our population is as follows: 85% are Minnan descendants, 5% are Hakka descendants, and the remaining 10% are mixed population of Minnan, Hakka, and Canton descendants. There was no significant difference in the MHC region among these groups, this indicated that the population in this study was homogeneous and population stratification should not affect this study. Moreover, the deviations from HWE might be a sign of mutation. This disequilibrium seems to also support the association of the polymorphisms in <italic>TGF-&#x003b2;2</italic> with high myopia.</p><p>The expression of <italic>TGF-&#x003b2;1</italic> and <italic>TGF-&#x003b2;2</italic> were different in myopia. A study by Hayashi et al. [<xref ref-type="bibr" rid="r23">23</xref>] revealed that there was no significant relationship between high myopia and <italic>TGF-&#x003b2;1</italic> among the Japanese [<xref ref-type="bibr" rid="r23">23</xref>]. Furthermore, Kusakari et al. [<xref ref-type="bibr" rid="r24">24</xref>] reported that <italic>TGF-&#x003b2;1</italic> expression was reduced in the sclera, choroid, and retina during myopia development in an isoform- and time-specific manner. However, it has been shown that the TGF-&#x003b2;2 content increased in the retina, choroid, and sclera during myopia development [<xref ref-type="bibr" rid="r25">25</xref>]. In this study, we found that expression of <italic>TGF-&#x003b2;2</italic> was different from the result of <italic>TGF-&#x003b2;1</italic> among the Japanese. The different expressions of <italic>TGF-&#x003b2;2</italic> and <italic>TGF-&#x003b2;1</italic> in myopia could be understood by the different behavior of the two isoforms in sclera during the progression of myopia. Moreover, our other study has found that the CC genotype in the <italic>TGF-&#x003b2;1</italic> codon 10 polymorphism (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1800470">rs1982073</ext-link>) contributes to the genetic predisposition of high myopia [<xref ref-type="bibr" rid="r18">18</xref>]. The SNP we detected (<italic>TGF-&#x003b2;1</italic> [<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1800470">rs1982073</ext-link>]) was not the purpose in the study of Hayashi et al. [<xref ref-type="bibr" rid="r23">23</xref>], which is about the relation of <italic>TGF-&#x003b2;1</italic> and myopia in the Japanese. To refine the role of <italic>TGF-&#x003b2;1</italic> in myopia, it is still necessary to study the expression of <italic>TGF-&#x003b2;1</italic> in other populations. Studies on the TGF-&#x003b2;-induced factor gene<italic/>(<italic>TGIF</italic>) [<xref ref-type="bibr" rid="r26">26</xref>] had revealed that <italic>TGIF</italic> 657 T&#x02192;G was a useful marker for high myopia. The target genes of these studies were related to <italic>TGF-&#x003b2;1</italic> and not <italic>TGF-&#x003b2;</italic>, which was surveyed in this study. These data may be collected together for mapping high myopia in the future. TGF-&#x003b2; is one of the growth factors released from photoreceptor and retina pigment epithelium layer in the retina [<xref ref-type="bibr" rid="r27">27</xref>], TGF-&#x003b2; demonstrated a different broad range of function [<xref ref-type="bibr" rid="r28">28</xref>]. A previous study had proposed that the concentration of <italic>TGF-&#x003b2;</italic> mRNA and active form of the TGF-&#x003b2; protein will decrease in the form-deprived myopia eyes compared with the control group [<xref ref-type="bibr" rid="r29">29</xref>]. Consequently, TGF-&#x003b2; may mediate the control of ocular axial elongation then influence the progression of high myopia [<xref ref-type="bibr" rid="r29">29</xref>]. A recent study about TGF-&#x003b2; revealed that reduced scleral TGF-&#x003b2; is a major contributor to the extracellular matrix remodeling in the myopic eye. In the progression of myopia, remodeling of scleral and producing a larger population of contractile cells are the important process [<xref ref-type="bibr" rid="r28">28</xref>]. These findings all revealed that important role of TGF-&#x003b2; in myopia. The function assay of <italic>TGFb2</italic>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7550232">rs7550232</ext-link> and the genetic regulation the SNP is worthy of further investigation. </p><p>Myopia is considered to be a complex and multigenic disease involving several overlapping signaling pathways, each one mediated by a group of distinct genetic profiles. Therefore, it is important to study the polymorphisms involved in the development of myopia to further clarify the relationship between genes and myopia. In this study we prevented the effects of environment by selected the study and control groups from medical school students. Nevertheless, the &#x0201c;environment&#x0201d; effects cannot be completely prevented. Moreover, the incidence of myopia in our country increased in the past 20 years [<xref ref-type="bibr" rid="r30">30</xref>]; these all indicated that the effective of environment would not be over-emphasized. Although the results of this study could give us the genetic information of myopia, the prevention of high myopia still needs the efforts of eye doctors and the association of public health.</p></sec></body><back><ack><title>Acknowledgments</title><p>The studies were supported by grants of China Medical University Hospital and from the National Science Council, Taiwan (NSC 96-2628-B-039-002-MY3). Co-Corresponding authors: Lei Wan, Ph.D., and Fuu-Jen Tsai, M.D., Ph.D., Department of Medical Genetics, China Medical University Hospital, No. 2 Yuh Der Road, Taichung 404, Taiwan; Phone: 886-4-22052121 ext. 2041; FAX: 886-4-22033295; email: d0704@mail.cmuh.org.tw (Dr. Wan and Dr. Tsai contributed equally to this research project and they are co-corresponding authors).</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sperduto</surname><given-names>RD</given-names></name><name><surname>Seigel</surname><given-names>D</given-names></name><name><surname>Roberts</surname><given-names>J</given-names></name><name><surname>Rowland</surname><given-names>M</given-names></name></person-group><article-title>Prevalence of myopia in the United States.</article-title><source>Arch Ophthalmol</source><year>1983</year><volume>101</volume><fpage>405</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">6830491</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goh</surname><given-names>WS</given-names></name><name><surname>Lam</surname><given-names>CS</given-names></name></person-group><article-title>Changes in refractive trends and optical components of Hong Kong Chinese aged 19&#x02013;39 years.</article-title><source>Ophthalmic Physiol Opt</source><year>1994</year><volume>14</volume><fpage>378</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">7845695</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>LL</given-names></name><name><surname>Shih</surname><given-names>YF</given-names></name><name><surname>Tsai</surname><given-names>CB</given-names></name><name><surname>Chen</surname><given-names>CJ</given-names></name><name><surname>Lee</surname><given-names>LA</given-names></name><name><surname>Hung</surname><given-names>PT</given-names></name><name><surname>Hou</surname><given-names>PK</given-names></name></person-group><article-title>Epidemiologic study of ocular refraction among schoolchildren in Taiwan in 1995.</article-title><source>Optom Vis Sci</source><year>1999</year><volume>76</volume><fpage>275</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">10375241</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celorio</surname><given-names>JM</given-names></name><name><surname>Pruett</surname><given-names>RC</given-names></name></person-group><article-title>Prevalence of lattice degeneration and its relation to axial length in severe myopia.</article-title><source>Am J Ophthalmol</source><year>1991</year><volume>111</volume><fpage>20</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">1985485</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grey</surname><given-names>RH</given-names></name><name><surname>Burns-Cox</surname><given-names>CJ</given-names></name><name><surname>Hughes</surname><given-names>A</given-names></name></person-group><article-title>Blind and partial sight registration in Avon.</article-title><source>Br J Ophthalmol</source><year>1989</year><volume>73</volume><fpage>88</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">2930763</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldkamper</surname><given-names>M</given-names></name><name><surname>Schaeffel</surname><given-names>F</given-names></name></person-group><article-title>Interactions of genes and environment in myopia.</article-title><source>Dev Ophthalmol</source><year>2003</year><volume>37</volume><fpage>34</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">12876828</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBrien</surname><given-names>NA</given-names></name><name><surname>Jobling</surname><given-names>AI</given-names></name><name><surname>Gentle</surname><given-names>A</given-names></name></person-group><article-title>Biomechanics of the sclera in myopia: extracellular and cellular factors.</article-title><source>Optom Vis Sci</source><year>2009</year><volume>86</volume><fpage>E23</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">19104466</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohrer</surname><given-names>B</given-names></name><name><surname>Stell</surname><given-names>WK</given-names></name></person-group><article-title>Basic fibroblast growth factor (bFGF) and transforming growth factor beta (TGF-beta) act as stop and go signals to modulate postnatal ocular growth in the chick.</article-title><source>Exp Eye Res</source><year>1994</year><volume>58</volume><fpage>553</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">7925692</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jobling</surname><given-names>AI</given-names></name><name><surname>Wan</surname><given-names>R</given-names></name><name><surname>Gentle</surname><given-names>A</given-names></name><name><surname>Bui</surname><given-names>BV</given-names></name><name><surname>McBrien</surname><given-names>NA</given-names></name></person-group><article-title>Retinal and choroidal TGF-beta in the tree shrew model of myopia: isoform expression, activation and effects on function.</article-title><source>Exp Eye Res</source><year>2009</year><volume>88</volume><fpage>458</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">19046968</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>AB</given-names></name><name><surname>Sporn</surname><given-names>MB</given-names></name></person-group><article-title>Differential expression of the TGF-beta isoforms in embryogenesis suggests specific roles in developing and adult tissues.</article-title><source>Mol Reprod Dev</source><year>1992</year><volume>32</volume><fpage>91</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">1637557</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornell</surname><given-names>RA</given-names></name><name><surname>Kimelman</surname><given-names>D</given-names></name></person-group><article-title>Activin-mediated mesoderm induction requires FGF.</article-title><source>Development</source><year>1994</year><volume>120</volume><fpage>453</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">8149920</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBrien</surname><given-names>NA</given-names></name><name><surname>Metlapally</surname><given-names>R</given-names></name><name><surname>Jobling</surname><given-names>AI</given-names></name><name><surname>Gentle</surname><given-names>A</given-names></name></person-group><article-title>Expression of collagen-binding integrin receptors in the mammalian sclera and their regulation during the development of myopia.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2006</year><volume>47</volume><fpage>4674</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">17065473</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>TL</given-names></name><name><surname>Guo</surname><given-names>XD</given-names></name><name><surname>King</surname><given-names>RA</given-names></name><name><surname>Johnson</surname><given-names>JM</given-names></name><name><surname>Rada</surname><given-names>JA</given-names></name></person-group><article-title>Identification of genes expressed in a human scleral cDNA library.</article-title><source>Mol Vis</source><year>2003</year><volume>9</volume><fpage>508</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">14551531</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chugh</surname><given-names>R</given-names></name><name><surname>Wathen</surname><given-names>JK</given-names></name><name><surname>Maki</surname><given-names>RG</given-names></name><name><surname>Benjamin</surname><given-names>RS</given-names></name><name><surname>Patel</surname><given-names>SR</given-names></name><name><surname>Myers</surname><given-names>PA</given-names></name><name><surname>Priebat</surname><given-names>DA</given-names></name><name><surname>Reinke</surname><given-names>DK</given-names></name><name><surname>Thomas</surname><given-names>DG</given-names></name><name><surname>Keohan</surname><given-names>ML</given-names></name><name><surname>Samuels</surname><given-names>BL</given-names></name><name><surname>Baker</surname><given-names>LH</given-names></name></person-group><article-title>Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model.</article-title><source>J Clin Oncol</source><year>2009</year><volume>27</volume><fpage>3148</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">19451433</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>NF</given-names></name><name><surname>Gale</surname><given-names>CR</given-names></name><name><surname>Ye</surname><given-names>S</given-names></name><name><surname>Martyn</surname><given-names>CN</given-names></name></person-group><article-title>Myopia and polymorphisms in genes for matrix metalloproteinases.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2009</year><volume>50</volume><fpage>2632</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">19279308</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>W</given-names></name><name><surname>Leung</surname><given-names>KH</given-names></name><name><surname>Fung</surname><given-names>WY</given-names></name><name><surname>Mak</surname><given-names>JY</given-names></name><name><surname>Li</surname><given-names>YM</given-names></name><name><surname>Yap</surname><given-names>MK</given-names></name><name><surname>Yip</surname><given-names>SP</given-names></name></person-group><article-title>Association of PAX6 polymorphisms with high myopia in Han Chinese nuclear families.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2009</year><volume>50</volume><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">19124844</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>WC</given-names></name><name><surname>Yip</surname><given-names>SP</given-names></name><name><surname>Lo</surname><given-names>KK</given-names></name><name><surname>Ng</surname><given-names>PW</given-names></name><name><surname>Choi</surname><given-names>PS</given-names></name><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Yap</surname><given-names>MK</given-names></name></person-group><article-title>inkage and association of myocilin (MYOC) polymorphisms with high myopia in a Chinese population.</article-title><source>Mol Vis</source><year>2007</year><volume>13</volume><fpage>534</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">17438518</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>HJ</given-names></name><name><surname>Wan</surname><given-names>L</given-names></name><name><surname>Tsai</surname><given-names>Y</given-names></name><name><surname>Tsai</surname><given-names>YY</given-names></name><name><surname>Fan</surname><given-names>SS</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name></person-group><article-title>The TGFbeta1 gene codon 10 polymorphism contributes to the genetic predisposition to high myopia.</article-title><source>Mol Vis</source><year>2006</year><volume>12</volume><fpage>698</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">16807529</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewitt</surname><given-names>AW</given-names></name><name><surname>Kearns</surname><given-names>LS</given-names></name><name><surname>Jamieson</surname><given-names>RV</given-names></name><name><surname>Williamson</surname><given-names>KA</given-names></name><name><surname>van Heyningen</surname><given-names>V</given-names></name><name><surname>Mackey</surname><given-names>DA</given-names></name></person-group><article-title>PAX6 mutations may be associated with high myopia.</article-title><source>Ophthalmic Genet</source><year>2007</year><volume>28</volume><fpage>179</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">17896318</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inamori</surname><given-names>Y</given-names></name><name><surname>Ota</surname><given-names>M</given-names></name><name><surname>Inoko</surname><given-names>H</given-names></name><name><surname>Okada</surname><given-names>E</given-names></name><name><surname>Nishizaki</surname><given-names>R</given-names></name><name><surname>Shiota</surname><given-names>T</given-names></name><name><surname>Mok</surname><given-names>J</given-names></name><name><surname>Oka</surname><given-names>A</given-names></name><name><surname>Ohno</surname><given-names>S</given-names></name><name><surname>Mizuki</surname><given-names>N</given-names></name></person-group><article-title>The COL1A1 gene and high myopia susceptibility in Japanese.</article-title><source>Hum Genet</source><year>2007</year><volume>122</volume><fpage>151</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17557158</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paluru</surname><given-names>P</given-names></name><name><surname>Ronan</surname><given-names>SM</given-names></name><name><surname>Heon</surname><given-names>E</given-names></name><name><surname>Devoto</surname><given-names>M</given-names></name><name><surname>Wildenberg</surname><given-names>SC</given-names></name><name><surname>Scavello</surname><given-names>G</given-names></name><name><surname>Holleschau</surname><given-names>A</given-names></name><name><surname>M&#x000e4;kitie</surname><given-names>O</given-names></name><name><surname>Cole</surname><given-names>WG</given-names></name><name><surname>King</surname><given-names>RA</given-names></name><name><surname>Young</surname><given-names>TL</given-names></name></person-group><article-title>New locus for autosomal dominant high myopia maps to the long arm of chromosome 17.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2003</year><volume>44</volume><fpage>1830</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12714612</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>WH</given-names></name><name><surname>Fann</surname><given-names>CS</given-names></name><name><surname>Wu</surname><given-names>JY</given-names></name><name><surname>Hung</surname><given-names>YT</given-names></name><name><surname>Ho</surname><given-names>MS</given-names></name><name><surname>Tai</surname><given-names>TH</given-names></name><name><surname>Chen</surname><given-names>YJ</given-names></name><name><surname>Liao</surname><given-names>CJ</given-names></name><name><surname>Yang</surname><given-names>ML</given-names></name><name><surname>Cheng</surname><given-names>AT</given-names></name><name><surname>Chen</surname><given-names>YT</given-names></name></person-group><article-title>Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations.</article-title><source>Hum Hered</source><year>2006</year><volume>61</volume><fpage>27</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">16534213</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Inoko</surname><given-names>H</given-names></name><name><surname>Nishizaki</surname><given-names>R</given-names></name><name><surname>Ohno</surname><given-names>S</given-names></name><name><surname>Mizuki</surname><given-names>N</given-names></name></person-group><article-title>Exclusion of transforming growth factor-beta1 as a candidate gene for myopia in the Japanese.</article-title><source>Jpn J Ophthalmol</source><year>2007</year><volume>51</volume><fpage>96</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17401617</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusakari</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Tokoro</surname><given-names>T</given-names></name></person-group><article-title>Visual deprivation stimulates the exchange of the fibrous sclera into the cartilaginous sclera in chicks.</article-title><source>Exp Eye Res</source><year>2001</year><volume>73</volume><fpage>533</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">11825024</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>QH</given-names></name><name><surname>Singh</surname><given-names>RP</given-names></name><name><surname>Richardson</surname><given-names>TP</given-names></name><name><surname>Nugent</surname><given-names>MA</given-names></name><name><surname>Trinkaus-Randall</surname><given-names>V</given-names></name></person-group><article-title>Transforming growth factor-beta1 expression in cultured corneal fibroblasts in response to injury.</article-title><source>J Cell Biochem</source><year>2000</year><volume>77</volume><fpage>186</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">10723086</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saw</surname><given-names>SM</given-names></name><name><surname>Cheng</surname><given-names>A</given-names></name><name><surname>Fong</surname><given-names>A</given-names></name><name><surname>Gazzard</surname><given-names>G</given-names></name><name><surname>Tan</surname><given-names>DT</given-names></name><name><surname>Morgan</surname><given-names>I</given-names></name></person-group><article-title>School grades and myopia.</article-title><source>Ophthalmic Physiol Opt</source><year>2007</year><volume>27</volume><fpage>126</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17324201</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanihara</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Yoshimura</surname><given-names>N</given-names></name></person-group><article-title>Identification of transforming growth factor-beta expressed in cultured human retinal pigment epithelial cells.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1993</year><volume>34</volume><fpage>413</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8440596</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jobling</surname><given-names>AI</given-names></name><name><surname>Gentle</surname><given-names>A</given-names></name><name><surname>Metlapally</surname><given-names>R</given-names></name><name><surname>McGowan</surname><given-names>BJ</given-names></name><name><surname>McBrien</surname><given-names>NA</given-names></name></person-group><article-title>Regulation of scleral cell contraction by transforming growth factor-beta and stress: competing roles in myopic eye growth.</article-title><source>J Biol Chem</source><year>2009</year><volume>284</volume><fpage>2072</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19011237</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honda</surname><given-names>S</given-names></name><name><surname>Fujii</surname><given-names>S</given-names></name><name><surname>Sekiya</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name></person-group><article-title>Retinal control on the axial length mediated by transforming growth factor-beta in chick eye.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1996</year><volume>37</volume><fpage>2519</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">8933768</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>TJ</given-names></name><name><surname>Chiang</surname><given-names>TH</given-names></name><name><surname>Wang</surname><given-names>TH</given-names></name><name><surname>Lin</surname><given-names>LL</given-names></name><name><surname>Shih</surname><given-names>YF</given-names></name></person-group><article-title>Changes of the ocular refraction among freshmen in National Taiwan University between 1988 and 2005.</article-title><source>Eye</source><year>2009</year><volume>23</volume><fpage>1168</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18551136</pub-id></mixed-citation></ref></ref-list></back></article>